2-[(1R,3R)-2-{2-[(3R)-5,8-dioxo-1,3-bis(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-hexahydro-1H-[1,2,4]diazaphospholo[1,2-a]pyridazin-2-yl]phenyl}-5,8-dioxo-3-(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-hexahydro-1H-[1,2,4]diazaphospholo[1,2-a]pyridazin-1-yl]-N-[(1S)-1-phenylethyl]benzamide

• ChemBase编号: 140685
• 分子式: C78H72N8O8P2
• 平均质量: 1311.402602
• 单一同位素质量: 1310.49483456
• SMILES: C[C@@H](c1ccccc1)NC(=O)c1ccccc1[C@@H]1N2C(=O)CCC(=O)N2[C@H](P1c1ccccc1P1[C@@H](N2C(=O)CCC(=O)N2C1c1ccccc1C(=O)N[C@@H](C)c1ccccc1)c1ccccc1C(=O)N[C@@H](C)c1ccccc1)c1ccccc1C(=O)N[C@@H](C)c1ccccc1
• Canonical SMILES: O=C1CCC(=O)N2N1C(P([C@@H]2c1ccccc1C(=O)N[C@H](c1ccccc1)C)c1ccccc1P1[C@@H](N2N([C@H]1c1ccccc1C(=O)N[C@H](c1ccccc1)C)C(=O)CCC2=O)c1ccccc1C(=O)N[C@H](c1ccccc1)C)c1ccccc1C(=O)N[C@H](c1ccccc1)C
• InChI: InChI=1S/C78H72N8O8P2/c1-49(53-27-9-5-10-28-53)79-71(91)57-35-17-21-39-61(57)75-83-67(87)45-46-68(88)84(83)76(62-40-22-18-36-58(62)72(92)80-50(2)54-29-11-6-12-30-54)95(75)65-43-25-26-44-66(65)96-77(63-41-23-19-37-59(63)73(93)81-51(3)55-31-13-7-14-32-55)85-69(89)47-48-70(90)86(85)78(96)64-42-24-20-38-60(64)74(94)82-52(4)56-33-15-8-16-34-56/h5-44,49-52,75-78H,45-48H2,1-4H3,(H,79,91)(H,80,92)(H,81,93)(H,82,94)/t49-,50-,51-,52?,75+,76+,77+,78?,96?/m0/s1
• InChIKey: NTWCWWNZWYJTEP-VZMBVJTDSA-N

名称和登记号

名称

• IUPAC标准名: 2-[(1R,3R)-2-{2-[(3R)-5,8-dioxo-1,3-bis(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-hexahydro-1H-[1,2,4]diazaphospholo[1,2-a]pyridazin-2-yl]phenyl}-5,8-dioxo-3-(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-hexahydro-1H-[1,2,4]diazaphospholo[1,2-a]pyridazin-1-yl]-N-[(1S)-1-phenylethyl]benzamide
• IUPAC传统名: 2-[(1R,3R)-2-{2-[(3R)-5,8-dioxo-1,3-bis(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-tetrahydro-[1,2,4]diazaphospholo[1,2-a]pyridazin-2-yl]phenyl}-5,8-dioxo-3-(2-{[(1S)-1-phenylethyl]carbamoyl}phenyl)-tetrahydro-[1,2,4]diazaphospholo[1,2-a]pyridazin-1-yl]-N-[(1S)-1-phenylethyl]benzamide
• 别名: 2,2′,2″,2′′′-(1,2-亚苯基双[(1R,3R)-四氢-5,8-二氧代-1H-[1,2,4]二氮杂磷杂环戊基[1,2-a]哒嗪-2,1,3(3H)-三基])四(N-[(1S)-1-苯乙基])苯甲酰胺; Bis[(R,R,S)-DiazaPhos-SPE]; 2,2′,2″,2′′′-(1,2-Phenylenebis[(1R,3R)-tetrahydro-5,8-dioxo-1H-[1,2,4]diazaphospholo[1,2-a]pyridazine-2,1,3(3H)-triyl])tetrakis(N-[(1S)-1-phenylethyl])benzamide; Bis[(R,R,S)-DiazaPhos-SPE]

登记号

• CAS号: 851609-33-1
• PubChem SID: 162234926
• PubChem CID: 71310490

理论计算性质

• Acid pKa: 14.302624
• 质子受体: 8
• 质子供体: 4
• LogD (pH = 5.5): 11.686199
• LogD (pH = 7.4): 11.6862
• Log P: 11.6862
• 摩尔折射率: 370.7514 cm^3
• 极化性: 142.57104 Å^3
• 极化表面积: 197.64 Å^2
• 可自由旋转的化学键: 18
• 里宾斯基五规则: false

分子性质

理化性质

• 熔点: 183-195 °C
• 比旋光度: [α]20/D -82.0°, c = 1 in THF

安全信息

• 德国WGK号: 3

产品相关信息

• Empirical Formula (Hill Notation): C78H72N8O8P2

详细说明

Sigma Aldrich - 685232

Application
二氮杂磷杂环戊烷配体在 Rh-催化的不对称氢甲酰化反应中显示出优良的转化水平和选择性。5,4
Diazaphospholane Ligands for Catalytic Asymmetric TransformationsCatalyst for:
• Enantioselective synthesis of α,β-unsaturated aldehydes via hydroformylation of dienes1
• Regioselective and enantioselective hydroformylation of dialkyl acrylamides2
• Asymmetric hydroformylation of vinyl acetate3
• Regioselective and stereoselective hydroformylation of alkenes4
包装
1 g in glass bottle
500 mg in glass bottle
Legal Information
产品的销售仅限于 R&D 目的并且不允许最终用户在商业产品生产中使用。与 DowpharmaSM（Dow Chemical Company 的业务单位）联合销售产品。美国专利7,071,357B。